Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
In what circumstances would you recommend using DIBH in patients with breast cancer during an electron boost?
Answer from: Radiation Oncologist at Community Practice
Sometimes use for breast boost for lower quadrant disease if exit beam is close to the heart to decrease heart dose.
Comments
Radiation Oncologist at Mountain Radiation Oncology
Have you run plans to quantitate the reduction of ...
Radiation Oncologist at Providence St Mary Cancer Center
I went ahead and tried this. The heart was fully i...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Mean dose will not change much as the total dose a...
5328
5329
5330
Sign in or Register to read more
11303
Related Questions
Would you start any treatment for radiation pneumonitis if there is a large area of consolidation in the irradiated lung field but the patient is asymptomatic?
In the post-mastectomy setting, are there situations where only the regional nodes or targeted nodal basis are covered?
Would you offer APBI to a patient with very large breast anatomy and a small lumpectomy cavity after an oncoplastic closure?
When treating APBI with the Florence regimen, are you using daily or every other day fractionation?
In patients with history of prior axillary surgery, subsequently with breast cancer recurrence, and sentinel lymph nodes mapped to internal mammary area (but were not biopsied), do you offer post-mastectomy radiation to cover the IMNs?
When treating early stage breast cancer with adjuvant RT, what risk factors would lead you to include the level 1 and 2 axilla in patients with pN0(i+) disease?
What is your preferred method of surveillance after mastectomy?
Do you prefer to use the FAST or FAST-Forward regimen when treating stage I breast cancer with an ultra-hypofractionated approach?
In a patient with T2N0 breast cancer with skin involvement s/p lumpectomy and negative margins, if you are offering whole breast radiation, would you bolus your tangent fields?
In patients with HER-2 positive breast cancer on pertuzumab/trastuzumab with newly developed asymptomatic brain metastases only, do you wait 3 weeks after administration of the targeted therapy to deliver SRS?
Have you run plans to quantitate the reduction of ...
I went ahead and tried this. The heart was fully i...
Mean dose will not change much as the total dose a...